8/30/2022Henlius CEO Scouts for US PD-1 Partner Amid Fosun Unit's Pivot to Inno...

8/30/2022Drug Discovery in China: A Snapshot of Recent Progress (ScienceDirect)

8/29/2022A Look at the CDE's 2021 Drug Review Report

8/29/2022CDE Solicits Comments on Draft Technical Guidelines for Pharmaceutical...

8/29/2022CDE Issues the List of Reference Formulations for GQCE Studies (57th B...

8/29/2022Porton Advanced, Royaltech Accelerate Development of mRNA Drugs in Chi...

8/26/2022NMPA Announces OTC Switch of Omeprazole Enteric-Coated Tablets

8/26/2022Recent Official and Executive Moves

8/26/2022Drug R&D and Product Registration News Digest August 2022 (4)

8/24/2022Chinese Vaccine Regulatory System Passes New WHO Assessment for ML3 Ra...

8/24/2022NMPA Suspends Import, Sales and Use of UCB's Epilepsy Drug Keppra

8/24/2022Windtree Therapeutics Out-licenses Surfactant Platform in a $79M Globa...

8/24/2022Four Publicly Traded Drugmakers Saw Huge Investments in July

8/23/2022Hansoh Licenses Covid Drug Candidate GDI-4405 from GHDDI

8/22/2022CDE Publishes the Annual Report on Chinese New Drug Registration Clini...

8/22/2022Drug R&D and Approvals in China – July Update on YouTube (PharmCube)

8/22/2022New Rational Drug Use Rules in China Benefit Pediatric, Anti-Tumor And...

8/19/2022An Online Survey of Primary Care Physicians' Knowledge of Common Respi...

8/19/2022Lundbeck Fails China Trial for CGRP Migraine Drug Vyepti, Undermining ...

8/19/2022Pfizer Signs China Partnership to Make Paxlovid Covid Pills Locally

8/19/2022Drug R&D and Product Registration News Digest August 2022 (3)

8/18/2022Roche to Pay $60M Upfront in License Deal for Jemincare's Potential Pr...

8/18/2022CDE Solicits Comments on the Draft "Technical Guidelines for Clinical ...

8/18/202217 Central Government Agencies Jointly Introduce New Incentives for Co...

8/18/2022Kidney Disease Drugs A Hot Spot for July In-licensing (PharmaDJ)

8/18/2022Vision 2028: How China Could Impact the Global Biopharma Industry (McK...

8/17/2022Gilead to Acquire Remaining Worldwide Rights of Trodelvy from Everest ...

8/17/2022AbbVie to Discontinue Phase 1 Trial for I-Mab's Anti-CD47 Therapy for ...

8/17/2022Review of Chinese Biopharma Licensing Trends 2016-2021

8/17/2022Review of Chinese Retail Drug Sales in Q1/2022

Page:153/798 Total number of articles:23926: [First][<<] [151] [152] [153] [154] [155] [>>] [End]